PI 3–kinase is a lipid kinase that generates 3-phosphorylated
phosphoinositides in cells stimulated with a variety of agonists,
including EGF and platelet-derived growth factor.
2 Although the physiological significance of these lipids remains
elusive, increasing evidence suggests that they may function as
intracellular second-messenger molecules in several cellular processes
including cell growth and proliferation, cell differentiation,
protection from apoptosis, actin–cytoskeleton rearrangement, membrane
ruffling, and vesicle transport.
4 The data presented
herein demonstrate that there is a marked increase in PI 3–kinase
activity in the regenerating corneal epithelium. This increase in PI
3–kinase activity appeared to correlate with the time course of wound
repair, except at 48 hours when the enzyme activity started to decline
although the wound had not completely repaired yet. As mentioned above,
after the creation of corneal wounds there is increased production of
EGF in the tear film. Therefore, the observed increase in PI 3–kinase
activity during reepithelialization of the untreated cornea is probably
due to endogenous EGF present in the vicinity of the wound. Additional
topical application of EGF to the wounded corneal epithelium further
enhanced the PI 3–kinase activity. This increase in PI 3–kinase
activity was peaked at 36 hours, a time when the epithelial wound had
nearly healed. At 48 hours, when the epithelial wound was completely
healed, the enzyme activity had significantly declined from its peak
value. After this, the enzyme activity gradually decreased to the
baseline over the course of the next several days (data not shown).
These data could suggest that even though the wound appears to be
closed, the cells probably are still undergoing the repair process.
Therefore, wound closure may not necessarily indicate the end of wound
healing. Using a cell culture model for corneal epithelial wound
repair, we have previously shown that both EGF-induced PI 3–kinase
activation and wound repair were inhibited when the cells were treated
with wortmannin, a PI 3–kinase inhibitor,
11 suggesting a
causal relationship between the two EGF-induced effects. The data
obtained from rabbit corneal epithelium, in vivo, also suggest a
possible correlation between PI 3–kinase activation and corneal
epithelial wound repair. There are several reports implicating PI
3–kinase in the regulation of cell growth and proliferation by
receptor tyrosine kinases,
21 nonreceptor tyrosine
kinases,
22 and cytokine receptors.
23 More
recently, PI 3–kinase was shown to induce migration in several
epithelial cell lines, suggesting that PI 3–kinase may have a role in
wound healing and tissue repair.
24 In corneal endothelial
cells, cell proliferation induced by fibroblast growth factor was
inhibited by wortmannin and LY294002 (a PI 3–kinase inhibitor), again
suggesting that PI 3–kinase might be involved in cell proliferation in
corneal endothelial cells.
25